🇺🇸 FDA
Pipeline program

glucocorticoid plus iguratimod

IgG4-RD, superficial organ

Unknown small_molecule active

Quick answer

glucocorticoid plus iguratimod for Autoimmune Diseases is a Unknown program (small_molecule) at Peking University Third Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Peking University Third Hospital
Indication
Autoimmune Diseases
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials